Allergan, Inc. (AGN) - Financial and Strategic SWOT Analysis Review

Date: March 3, 2015
Pages: 76
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AE368A76851EN
Leaflet:

Download PDF Leaflet

Allergan, Inc. (AGN) - Financial and Strategic SWOT Analysis Review
Allergan, Inc. (AGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Allergan, Inc. (Allergan) is a global healthcare company. It develops and commercializes novel pharmaceuticals, over-the-counter products, biologics and the medical devices addressing ophthalmic, neurological, medical aesthetic, medical dermatology, breast aesthetic, urological, and other specialty markets. The company’s research and development efforts focus on products and technologies related to wide range of specialty areas with significant unmet clinical needs. The company sells its products through a network of own distributors and direct subsidiaries in approximately 40 countries and through independent distributors in about 100 countries across the world. The major customers of the company include wholesalers, drug stores, pharmacies, opticians, merchandisers, food stores, hospitals, and medical practitioners among others. Allergan is headquartered in Irvine, California, the US.

Allergan, Inc. Key Recent Developments

Feb 04, 2015: Allergan Reports Fourth Quarter 2014 Operating Results
Oct 29, 2013: Allergan Reports Third Quarter 2013 Operating Results
Oct 23, 2013: FDA Approves JUVEDERM VOLUMA XC
Oct 04, 2013: Allergan Announces Quarterly Conference Call
Jul 31, 2013: Allergan Reports Second Quarter 2013 Operating Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Allergan, Inc. - Key Facts
Allergan, Inc. - Key Employees
Allergan, Inc. - Key Employee Biographies
Allergan, Inc. - Major Products and Services
Allergan, Inc. - Medical Equipment Pipeline Products Data
Allergan, Inc. Pipeline Products by Equipment Type
Allergan, Inc. Pipeline Products by Development Stage
Allergan, Inc. - Pharmaceutical Pipeline Products Data
Allergan, Inc., Pipeline Products by Therapy Area
Allergan, Inc., Pipeline Products by Development Phase
Allergan, Inc. - History
Allergan, Inc. - Company Statement
Allergan, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Allergan, Inc. - Key Manufacturing Facilities

SECTION 2 – COMPANY ANALYSIS

Allergan, Inc. - Business Description
Allergan, Inc. - Corporate Strategy
Allergan, Inc. - SWOT Analysis
SWOT Analysis - Overview
Allergan, Inc. - Strengths
Strength - Specialty Pharmaceuticals Segment
Strength - Healthy Liquidity Position
Strength - Focus on Research and Development
Strength - Success in International Markets
Allergan, Inc. - Weaknesses
Weakness - Patent Infringement Concerns
Allergan, Inc. - Opportunities
Opportunity - Strategic Initiatives
Opportunity - Global Dermatology Market
Opportunity - New Products
Allergan, Inc. - Threats
Threat - Competitive Landscape
Threat - Rapid Technological Change
Threat - Stringent Government Regulations
Allergan, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Allergan, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Allergan, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Allergan, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Allergan, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015
Allergan, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 04, 2015: Allergan Reports Fourth Quarter 2014 Operating Results
Jan 30, 2015: Clinical Study: Improved Breast Reconstruction Outcomes with Seri Scaffold
Dec 17, 2014: COTCHETT, PITRE & McCARTHY Files Class Action Lawsuit on Behalf of Persons Who Sold Allergan Stock Between February 25, 2014 and April 21, 2014
Nov 14, 2014: Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community
Nov 12, 2014: Allergan Board of Directors Announces Approval of Amendments to Company's Bylaws
Nov 12, 2014: FDA Approves New Styles of Allergan's NATRELLE 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants
Nov 04, 2014: Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit Against Valeant & Pershing Square
Oct 29, 2014: Allergan Canada Launches a 3D JUVEDERM Visualization iPad App Powered by ModiFace
Oct 27, 2014: Allergan Reports Third Quarter 2014 Operating Results
Oct 17, 2014: Allergan To Lay Off 40 Employees In Carlsbad, California

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Allergan, Inc., Key Facts
Allergan, Inc., Key Employees
Allergan, Inc., Key Employee Biographies
Allergan, Inc., Major Products and Services
Allergan, Inc. Number of Pipeline Products by Equipment Type
Allergan, Inc. Pipeline Products by Equipment Type
Allergan, Inc. Number of Pipeline Products by Development Stage
Allergan, Inc. Pipeline Products by Development Stage
Allergan, Inc., Number of Pipeline Products by Therapy Area
Allergan, Inc., Number of Pipeline Products by Development Stage
Allergan, Inc., Pipeline Products By Therapy Area and Development Phase
Allergan, Inc., History
Allergan, Inc., Subsidiaries
Allergan, Inc., Key Manufacturing Facilities
Allergan, Inc., Key Competitors
Allergan, Inc., Ratios based on current share price
Allergan, Inc., Annual Ratios
Allergan, Inc., Interim Ratios
Allergan, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Allergan, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Allergan, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Allergan, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015
Allergan, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Allergan, Inc. Pipeline Products by Equipment Type
Allergan, Inc. Pipeline Products by Development Stage
Allergan, Inc., Pipeline Products by Therapy Area
Allergan, Inc., Pipeline Products by Development Phase
Allergan, Inc., Performance Chart (2010 - 2014)
Allergan, Inc., Ratio Charts
Allergan, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Allergan, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Allergan, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Allergan, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

Allergan, Inc. (AGN) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: